Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study von Saliba, Faouzi, Duvoux, Christophe, Dharancy, Sébastien, Dumortier, Jérôme, Calmus, Yvon, Gugenheim, Jean, Kamar, Nassim, Salamé, Ephrem, Neau‐Cransac, Martine, Vanlemmens, Claire, Durand, François, Pageaux, Georges‐Philippe, Hardwigsen, Jean, Benkhatar, Yasmina, Derquenne, François, Conti, Filomena

Volltext